Drug interactions
Abiraterone + Bosentan
Severity: Moderate
Abiraterone and Bosentan: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Bosentan is a moderate CYP3A4 inducer and may lower abiraterone exposure, potentially reducing its efficacy in prostate cancer.
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to see why Abiraterone and Bosentan interact, what to do about it, and the sources.
- Mechanism of action
- Clinical management
- Evidence level
Free 14-day trial. No card needed.
Other interactions of Abiraterone
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
